CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Demylocan for Myelodysplastic Syndromes – Details

Brand Name Demylocan
Generic Name Decitabine
Tumour Type Other
Indication Myelodysplastic Syndromes
Review Status Not Filed
Manufacturer Pharmascience Inc.
Submission Type Non-Submission
Clarification CADTH is unable to recommend reimbursement of the relevant product because a submission to CADTH was not filed by the manufacturer.
Last Updated May 29, 2019